When I tried to prepare a presentation for NGS, I was surprised to find there's no such thing as an "original" paper for SOLiD.
Usually, there must be a proof-of-concept paper published first, then papers that came out of the platform's beta testers. This is how I have observed with other providers.
People often quote George Church's paper on the Polonator as the original proof-of-concept of SOLiD, but I disagree. The Polonator could have been a proof-of-concept for Complete Genomics, but IMO, sequential ligation, double interrogation, and colour space, all major features of SOLiD, were never discussed by the Church Lab.
How can ABI (or Agencourt Personal Genomics) get away with starting a platform's paper trail with a stem-cell paper?
Usually, there must be a proof-of-concept paper published first, then papers that came out of the platform's beta testers. This is how I have observed with other providers.
People often quote George Church's paper on the Polonator as the original proof-of-concept of SOLiD, but I disagree. The Polonator could have been a proof-of-concept for Complete Genomics, but IMO, sequential ligation, double interrogation, and colour space, all major features of SOLiD, were never discussed by the Church Lab.
How can ABI (or Agencourt Personal Genomics) get away with starting a platform's paper trail with a stem-cell paper?
Comment